Literature DB >> 1915581

Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes.

D Hillaire-Buys1, J Chapal, P Petit, M M Loubatières-Mariani.   

Abstract

The effects of ATP on the pancreatic vascular bed of the rat were studied under resting tone. ATP exerted two different effects depending on the concentration used: a slight vasodilatation in the 1.65-49.5 microM range which was statistically significant only at 16.5 microM and a concentration-related vasoconstriction in the 495-4 950 microM range. Theophylline, a P1 purinoceptor antagonist, did not modify the vasodilator effect of ATP. The existence of two P2 purinoceptor subtypes (P2y and P2x) in our preparation may be responsible for the dual effect of ATP. The P2y antagonist 2,2'pyridylisatogen (PIT) used at 5 microM, revealed a vasoconstrictor effect of ATP 165 microM, a concentration without effect per se. Furthermore, the transient vasoconstrictor effect of ATP 495 microM was changed into a long-lasting one in the presence of PIT. On the other hand, the blockade of P2x purinoceptors by the desensitizing agent, alpha,beta-methylene ATP, increased the vasodilator effect of ATP 16.5 microM. In conclusion, two subtypes of P2 purinoceptor do exist on the pancreatic vascular bed: P2y inducing vasodilatation and P2x inducing vasoconstriction. At vascular resting tone, the effect observed with ATP therefore depends on the concentration used and on the balance between P2y/P2x purinoceptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915581     DOI: 10.1016/0014-2999(91)90494-b

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Study of the mechanisms involved in adenosine-5'-O-(2-thiodiphosphate) induced relaxation of rat thoracic aorta and pancreatic vascular bed.

Authors:  B Saïag; D Hillaire-Buys; J Chapal; P Petit; D Pape; B Rault; H Allain; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.

Authors:  Anne Farret; Romain Filhol; Nathalie Linck; Michèle Manteghetti; Jacques Vignon; René Gross; Pierre Petit
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

3.  Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.

Authors:  B F King; C Dacquet; A U Ziganshin; D F Weetman; G Burnstock; P M Vanhoutte; M Spedding
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.

Authors:  M Alsaqati; S L F Chan; V Ralevic
Journal:  Purinergic Signal       Date:  2013-12-06       Impact factor: 3.765

5.  P2y purinoceptor responses of beta cells and vascular bed are preserved in diabetic rat pancreas.

Authors:  D Hillaire-Buys; R Gross; J Chapal; G Ribes; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

6.  Novel vasocontractile role of the P2Y₁₄ receptor: characterization of its signalling in porcine isolated pancreatic arteries.

Authors:  M Alsaqati; M L Latif; S L F Chan; V Ralevic
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.